US Activist Hedge Fund Institutional SEC 13D 13G — August 17, 2026

17-08-2026

Andrew Rechtschaffen and his affiliate AVR Capital Holdings, LLC filed a Schedule 13D disclosing beneficial ownership of 6,975,000 ordinary shares (26.85%) of Pinnacle Acquisition Corp, a blank-check company. The shares were acquired through a combination of founder shares purchased for $25,000, private placement units for $2,250,000, and public units for $10,000,000, for a total aggregate purchase price of $12,275,000. The filing details the ownership structure and lock-up agreements but does not indicate any immediate plans for a business combination or other major corporate actions.

• · The Sponsor purchased 7,187,500 Class B Founder Shares for $25,000 on April 7, 2026, then surrendered 1,437,500 shares for no consideration on July 21, 2026, leaving 5,750,000 Founder Shares.
• · On August 10, 2026, the Sponsor purchased 225,000 Placement Units at $10.00 per unit, and AVR Capital Holdings, LLC purchased 1,000,000 Public Units in the IPO.
• · The Placement Units and underlying securities are subject to a lock-up provision prohibiting transfer until after the initial business combination.
• · The Reporting Persons have no plans or proposals relating to any of the matters in Item 4 of Schedule 13D (e.g., extraordinary corporate transactions, changes in board or management).
• · No transactions in Ordinary Shares were effected by the Reporting Persons during the 60 days preceding the filing date, except those described in Items 4 and 6.

17-08-2026

Foresite Capital Fund VI LP, along with related Foresite Capital entities and James B. Tananbaum, filed a Schedule 13D disclosing beneficial ownership of 9,181,328 shares of Latigo Biotherapeutics, Inc. common stock, representing 14.5% of the 63,238,030 shares outstanding as of August 7, 2026. The filing details a series of investments since September 2022, including purchases of Series A-2 and Series B convertible preferred stock, convertible promissory notes, and a recent IPO purchase, with Tananbaum serving on the issuer's board. The filing is a routine beneficial ownership disclosure and does not indicate any regulatory or trading action.

• · James B. Tananbaum is a member of the board of directors of Latigo Biotherapeutics.
• · None of the Reporting Persons has been convicted in any criminal proceeding or subject to securities-related civil proceedings in the last five years.
• · The filing is a preliminary event type of 'Major Shareholder' and was filed on August 17, 2026.
• · The issuer, Latigo Biotherapeutics, is a pharmaceutical preparations company incorporated in Delaware.

17-08-2026

Seto Wai Yue, CEO and Chairlady of Dreamland Ltd, filed an amended Schedule 13D/A disclosing beneficial ownership of 1,149,890 ordinary shares (1,069,890 Class A and 80,000 Class B), representing 32.99% of total outstanding ordinary shares as of August 7, 2026. The shares were acquired through a private placement from the issuer (580,000 Class A and 72,000 Class B) and a purchase from Imperial Vision Fund SPC (320,000 Class A), all at $3.75 per share. The filing indicates increased ownership and investment intent, but no specific plans for changes in control or major corporate actions.

• · Class B shares carry 12 votes per share, while Class A shares carry 1 vote per share.
• · The reporting person's percentage of aggregate voting power is not disclosed, but due to Class B shares' higher voting rights, it may exceed 32.99%.
• · The acquisitions were completed on July 7, 2026 (private placement) and August 6, 2026 (purchase from Imperial Vision Fund).
• · The reporting person holds the shares for investment purposes and has no current plans for changes in control or major corporate actions.

17-08-2026

Coliseum Capital Management and related entities disclosed a 6.5% beneficial ownership stake in MasterBrand, Inc. as of June 30, 2026, with 13,200,117 shares held by CCM and its principals. The filing is an amendment to Schedule 13G, indicating passive investment intent. Ownership percentages range from 5.1% to 6.5% across the reporting entities.

• · The filing is an amendment to Schedule 13G, filed under Rule 13d-1(c), indicating passive investment.
• · The reporting persons may be deemed members of a group with respect to shares owned by CCP and a separate account managed by CCM.
• · The ownership percentage is based on 203,490,490 shares outstanding as of August 3, 2026.
• · All reporting persons disclaim beneficial ownership of shares held by others.

17-08-2026

Polar Asset Management Partners Inc. disclosed a 13.6% beneficial ownership stake in Aeon Acquisition I Corp. (AESP) as of June 30, 2026, holding 838,000 Class A Ordinary Shares. The filing is made under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to influence control. No prior period comparison is available in this filing, so no period-over-period changes are reported.

• · Polar Asset Management Partners Inc. is registered with the Ontario Securities Commission as an investment fund manager, portfolio manager, exempt market dealer, and commodity trading manager.
• · The shares are directly held by Polar Multi-Strategy Master Fund, a Cayman Islands exempted company, for which Polar Asset Management Partners Inc. serves as investment advisor.
• · The filing is made under Rule 13d-1(b), confirming the shares were not acquired to change or influence control of the issuer.

17-08-2026

Coliseum Capital Management, LLC and related entities filed a Schedule 13G/A disclosing aggregate beneficial ownership of 1,177,122 shares of Herc Holdings Inc. common stock, representing 3.3% of shares outstanding as of June 30, 2026. The filing reflects a passive investment stake with no intent to influence control, and ownership is spread across multiple funds and individual managers.

• · The filing is an amendment (Schedule 13G/A) filed on August 17, 2026, with a date of change of June 30, 2026.
• · All reporting persons disclaim beneficial ownership of shares held by other reporting persons except to the extent of their pecuniary interest.
• · The filing is made pursuant to Rule 13d-1(c), indicating a passive investor status.

17-08-2026

Polar Asset Management Partners Inc. filed a Schedule 13G/A with the SEC on August 17, 2026, disclosing beneficial ownership of 174,303 shares of Bitcoin Depot Inc. Class A Common Stock, representing 2.9% of the outstanding shares. These shares are issuable upon the exercise of warrants and call options. The filing indicates that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b).
• · Polar Asset Management Partners Inc. is an investment advisor registered with the Ontario Securities Commission.
• · The shares are held directly by Polar Multi-Strategy Master Fund (PMSMF), a Cayman Islands exempted company.
• · The filing date is August 17, 2026, with a date of change of June 30, 2026.

17-08-2026

L.I.A. Pure Capital Ltd. filed an amended Schedule 13G with the SEC on August 17, 2026, disclosing beneficial ownership of 162,503 ordinary shares of Rail Vision Ltd., representing 6.83% of the 2,281,329 shares outstanding as of the reporting date. The filing was made under Rule 13d-1(c) and certifies that the securities were not acquired to change or influence control of the issuer.

• · The warrant includes a blocker provision preventing exercise that would result in beneficial ownership exceeding 19.99% of ordinary shares.
• · The filing is an amendment (Schedule 13G/A) with a date of change of August 17, 2026.
• · The reporting person is based in Tel Aviv, Israel, and the issuer is based in Ra'anana, Israel.

17-08-2026

On August 14, 2026, Apollomics Inc. closed a PIPE transaction and note conversion with its Chairman and CEO, Hung-Wen (Howard) Chen, and his wholly-owned vehicle King Regent Management Limited. The transaction increased Mr. Chen's beneficial ownership to 1,453,029 Class A Shares, representing approximately 49.76% of outstanding shares, up from prior levels. The PIPE involved cash purchases of 370,000 shares at $15.00 per share and conversion of a convertible note into 166,667 shares at $12.00 per share, totaling $5,550,005 in cash proceeds for the company.

• · Mr. Chen waived the requirement that the company raise at least $10,000,000 in gross proceeds in connection with the financing.
• · The convertible promissory note was dated March 30, 2026, and its conversion was triggered by the Private Placement Transaction.
• · Mr. Chen has sole voting and dispositive power over 423,334 shares and shared power over 1,029,695 shares held by King Regent.
• · King Regent is a Seychelles-incorporated investment holding company wholly owned by Mr. Chen.
• · No other transactions in Class A shares were effected by the reporting persons during the past 60 days except the described transaction.

17-08-2026

Jakhongir Abidovich Artikkhodjaev transferred 3,000,000 shares of StageWise Strategies Corp. (STWI) to his controlled entity Tourism and Entertainment Group LLC (TEG LLC) on August 10, 2026, for $414,803 ($0.138 per share). Following the transfer, Artikkhodjaev's beneficial ownership decreased from 4,000,000 shares to 1,000,000 shares (79.8% of outstanding), while TEG LLC now holds 3,000,000 shares (59.5% of outstanding). The filing indicates no current plans for major corporate actions such as mergers, asset sales, or board changes.

• · The transfer was executed as an additional contribution to the charter fund of TEG LLC, valued at UZS 5,002,867,019 (approx. $414,803) based on an independent appraisal.
• · Artikkhodjaev's ownership interest in TEG LLC after the contribution is 99.9259%.
• · The transferred shares represent 74.178% of the total issued shares of STWI (based on 4,044,334 shares outstanding at the time of the agreement).
• · The filing states no current plans for mergers, asset sales, board changes, or other extraordinary corporate transactions.

17-08-2026

Tether Global Investments Fund, S.I.C.A.F., S.A., Tether Investments, S.A. de C.V., and Giancarlo Devasini filed a Schedule 13G/A disclosing beneficial ownership of 5,617,689 shares of Stablecoin Development Corp (formerly NovaBay Pharmaceuticals, Inc.) as of June 30, 2026, representing 9.99% of the outstanding common stock. The shares are held in the form of warrants subject to a 9.99% ownership limitation, and the Reporting Persons disclaim beneficial ownership of an additional 16,257,311 shares that would otherwise be convertible. The filing indicates a significant passive stake by Tether-related entities in the renamed pharmaceutical company.

• · The filing is an amendment (Schedule 13G/A) filed on August 17, 2026, with a date of change of June 30, 2026.
• · The subject company changed its name from NovaBay Pharmaceuticals, Inc. to Stablecoin Development Corp on February 7, 2009 (date of name change).
• · Tether Global Investments Fund, S.I.C.A.F., S.A. is organized under the laws of the Republic of El Salvador; Giancarlo Devasini is an Italian citizen.
• · The warrants are held directly by Tether Investments, a controlled subsidiary of Tether Global Investments Fund, S.I.C.A.F., S.A.
• · Giancarlo Devasini holds a greater than 50% voting interest in Tether Global Investments Fund, S.I.C.A.F., S.A., giving him indirect voting and dispositive power over the securities.
• · The Ownership Limitation prevents the Reporting Persons from converting warrants into shares that would cause aggregate beneficial ownership to exceed 9.99% of outstanding common stock.
• · The percentage ownership is calculated based on 50,615,437 shares outstanding plus 5,617,689 shares issuable upon warrant conversion.
• · The Reporting Persons certify that the securities were not acquired for the purpose of changing or influencing control of the issuer.

17-08-2026

A group of entities led by Terra Capital Partners, LLC and Vikram S. Uppal filed a Schedule 13G with the SEC on August 17, 2026, disclosing beneficial ownership of 3,185,182 shares (5.4%) of KKR Real Estate Finance Trust Inc. common stock. The filing is a passive investment disclosure under Rule 13d-1(c), with no intent to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating a passive investment intent.
• · Vaspen MS I, LLC holds 1,457,508 shares (2.5%) and Maspen MS I, LLC holds 1,727,674 shares (2.9%).
• · The ownership percentage is based on 58,577,948 shares outstanding as of July 20, 2026.
• · All reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.

17-08-2026

Commodore Capital LP and related entities disclosed a 5.1% beneficial ownership stake in InflaRx N.V., holding 7,475,000 ordinary shares as of August 10, 2026. The filing is a Schedule 13G, indicating passive investment intent, and the ownership percentage is based on 147,368,221 shares outstanding as of June 30, 2026. No period-over-period comparisons are available as this is an initial filing.

• · The filing is made under Rule 13d-1(c), confirming passive investment intent.
• · Commodore Capital LP serves as investment manager to Commodore Capital Master LP.
• · Michael Kramarz and Robert Egen Atkinson are managing partners exercising investment discretion.
• · The issuer's ordinary shares have a nominal value of €0.12 per share.

17-08-2026

Nantahala Capital Partners and related parties acquired beneficial ownership of 803,038 shares of Femasys Inc. common stock (9.99% of outstanding shares) on August 10, 2026, through a stock purchase agreement with total cash consideration of $11,999,705.22. The transaction included pre-funded warrants, common warrants (exercisable at $2.95/share), and milestone warrants contingent on revenue and stock price targets. A side letter grants Nantahala board representation and information rights, with a second board seat if beneficial ownership exceeds 20%, and restricts certain corporate actions without Nantahala's consent for up to ten years.

• · Milestone warrants become exercisable only when (i) U.S. quarterly revenue reaches at least $1,500,000 and (ii) VWAP ≥ 130% of exercise price for 20 of 30 consecutive trading days.
• · Common warrants expire three years after issuance; milestone warrants expire three years after effective date of resale registration statement or 45 days after milestone notice.
• · Beneficial ownership limitation of 9.99% applies to warrant exercises; can be increased on 61 days' notice.
• · Issuer must file a resale registration statement within 30 days of Purchase and use commercially reasonable efforts to have it declared effective within 60 days.
• · Side letter gives Nantahala board appointment rights for a decade as long as beneficial ownership is at least 15%; second board seat at 20% threshold.

17-08-2026

Fenelon Opportunity Fund Inc., along with The Gregory Fenelon Revocable Living Trust and Gregory Fenelon individually, filed a Schedule 13G disclosing beneficial ownership of 1,797,750 shares of Strategic Education, Inc. (STRA), representing a 7.5% stake. The filing indicates passive investment intent, as the filers certify the shares were not acquired to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · The filers certify that the securities were not acquired to change or influence control of the issuer.
• · The filing date is August 17, 2026, with the date of change also August 17, 2026.
• · The subject company, Strategic Education, Inc., is incorporated in Maryland and headquartered in Herndon, Virginia.

17-08-2026

On August 17, 2026, Talkspace, Inc. was acquired by Universal Health Services, Inc. (UHS) in a merger for $5.25 per share in cash. As a result, Qumra Capital II, L.P. and its affiliated reporting persons ceased to beneficially own any Talkspace securities, and the company's common stock will be delisted from Nasdaq and deregistered under the Exchange Act.

• · The merger was consummated on August 17, 2026, pursuant to the Agreement and Plan of Merger dated March 9, 2026.
• · Each outstanding share of Talkspace common stock (excluding certain shares) was converted into the right to receive $5.25 in cash.
• · Vested stock options were cancelled and converted into cash equal to the excess of $5.25 over the exercise price.
• · Vested but unsettled RSUs were cancelled and converted into the right to receive $5.25 per RSU.
• · Immediately prior to the Effective Time, all of Talkspace's directors, including Erez Shachar, resigned from the board.
• · The Voting Agreement between Qumra Capital and Talkspace automatically terminated upon consummation of the merger.
• · Talkspace's common stock will be delisted from Nasdaq and deregistered under Section 12(b) of the Exchange Act.

17-08-2026

Equinox Partners Investment Management LLC and related entities filed a Schedule 13G with the SEC on August 17, 2026, disclosing a 9.8% beneficial ownership stake in Gran Tierra Energy Inc. The filing, which amends a prior Schedule 13D, reports aggregate ownership of 3,474,582 shares of common stock as of August 13, 2026. The group includes Equinox Partners, L.P. (4.0%), Kuroto Fund LP (1.0%), Mason Hill Partners, LP (0.9%), and Sean M. Fieler (9.8%), with the filing certifying the shares were not acquired to influence control.

• · The filing is an amendment to a prior Schedule 13D, indicating a change in filing status from active to passive (Rule 13d-1(c)).
• · Equinox Partners Investment Management LLC holds shared voting and dispositive power over 1,408,547 shares held in client accounts.
• · The filing certifies that the securities were not acquired with the purpose or effect of changing or influencing control of the issuer.

17-08-2026

RA Capital Management, L.P. and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 5,295,690 shares of Latigo Biotherapeutics, Inc. common stock, representing 8.4% of the 63,238,030 shares outstanding as of August 10, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), with the filers certifying the securities were not acquired to change or influence control of the issuer.

• · The filing is made pursuant to Rule 13d-1(c), indicating a passive investment intent.
• · RA Capital Healthcare Fund directly holds all 5,295,690 shares; RA Capital Management serves as investment adviser with delegated voting and dispositive power.
• · The Fund has divested voting and investment power over the reported securities and cannot revoke that delegation on less than 61 days' notice.
• · Peter Kolchinsky and Rajeev Shah are controlling persons of RA Capital Management GP, LLC, the general partner of RA Capital Management.
• · The filers expressly disclaim status as a group for purposes of this Schedule 13G.

17-08-2026

Fenelon Opportunity Fund Inc., The Gregory Fenelon Revocable Living Trust, and Gregory Fenelon individually filed a Schedule 13G with the SEC on August 17, 2026, disclosing beneficial ownership of 9,463,500 shares of TKO Group Holdings, Inc. common stock, representing a 5.0% passive stake. The filing indicates the shares were acquired and are held for investment purposes without intent to change or influence control of the issuer.

• · The filing is made pursuant to Rule 13d-1(c), indicating a passive investment intent.
• · The filers disclaim any purpose or effect of changing or influencing control of the issuer.
• · The filing date is August 17, 2026.
• · The CUSIP for TKO Group Holdings, Inc. common stock is 87256C101.

17-08-2026

On August 10, 2026, HWH International Inc. sold 20,000,000 shares and warrants to purchase 160,000,000 shares at $0.63 per share to Smart Dynamics Technology Limited for $10,000,000, resulting in a change of control. Liu Ming Hui, President and Chairman of China Gas Holdings Limited, is the sole stockholder and director of Smart Dynamics Technology Limited and now holds indirect beneficial ownership of a combined 180,000,000 shares (on an as-converted basis), representing 94.8% of the company's outstanding common stock (29,726,400 shares). The transaction also granted Smart Dynamics the right to appoint three new directors to HWH's board, expanding it to eight members.

• · The warrants have an exercise price of $0.63 per share and expire on August 10, 2030.
• · The Securities Purchase Agreement includes anti-dilution rights for Smart Dynamics for two years, preventing HWH from issuing new equity without consent.
• · HWH is required to file a registration statement for the 20,000,000 shares and 160,000,000 warrant shares within 60 days of closing.
• · The source of funds for the purchase was Smart Dynamics' general working capital.
• · Liu Ming Hui is a citizen of the People's Republic of China; Smart Dynamics Technology Limited is a British Virgin Islands company.

17-08-2026

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G with the SEC on August 17, 2026, disclosing beneficial ownership of 2,052,166 shares of Groupon, Inc. common stock, representing 5.0% of the company's outstanding shares. The filing indicates the shares are held for investment purposes and not with the intent to change or influence control of Groupon.

• · The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.
• · The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander.
• · The filing includes a Joint Filing Agreement dated August 14, 2026.

17-08-2026

KKR Genetic Disorder L.P. and related entities filed a Schedule 13D/A on August 17, 2026, disclosing that after selling 5,000,000 shares of BridgeBio Pharma common stock at $77.415 per share in an underwritten offering, their aggregate beneficial ownership dropped to 9,232,739 shares (4.7% of outstanding common stock), down from above 5%. This filing serves as an exit filing as KKR is no longer a 5% beneficial owner. The offering closed on August 17, 2026, and KKR entered into a 30-day lock-up agreement.

• · The offering was made under BridgeBio's effective shelf registration statement on Form S-3ASR (File No. 333-297701), with a prospectus dated July 24, 2026, supplemented on August 13, 2026.
• · KKR Genetic Disorder L.P. entered into a lock-up agreement with the underwriters, restricting disposal or hedging of Common Stock for 30 days after the final prospectus supplement date, subject to exceptions.
• · An Alternative Vehicle (managed by an investment firm in which an indirect subsidiary of KKR Group Partnership L.P. has an ownership interest) purchased 133,900 shares of Preferred Stock for $1,000 per share on July 1, 2026.
• · The Reporting Persons ceased to be beneficial owners of more than 5% of Common Stock on August 17, 2026, making this an exit filing.

17-08-2026

Fenelon Opportunity Fund Inc., together with The Gregory Fenelon Revocable Living Trust and Gregory Fenelon individually, filed a Schedule 13G with the SEC on August 17, 2026, disclosing beneficial ownership of 19,804,200 shares of Celsius Holdings, Inc. common stock, representing a 7.8% stake. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.
• · The reporting persons disclaim membership in a group for purposes of Section 13(d) or 13(g) of the Act.
• · Gregory Fenelon is the Chief Executive Officer of Fenelon Opportunity Fund Inc. and trustee of The Gregory Fenelon Revocable Living Trust.
• · The address of the principal business office of the reporting persons is 1910 Pacific Avenue, Suite 2000, Dallas, TX 75201.

17-08-2026

Fenelon Opportunity Fund Inc., together with The Gregory Fenelon Revocable Living Trust and Gregory Fenelon individually, filed a Schedule 13G disclosing beneficial ownership of 4,420,500 shares of e.l.f. Beauty, Inc., representing a 7.5% stake. The filing is a passive investment disclosure under Rule 13d-1(c).

• · The filing was made on August 17, 2026.
• · The reporting persons disclaim any purpose or effect of changing or influencing control of e.l.f. Beauty.
• · The securities are held for investment purposes only.

17-08-2026

Fenelon Opportunity Fund Inc., along with The Gregory Fenelon Revocable Living Trust and Gregory Fenelon individually, filed a Schedule 13G disclosing beneficial ownership of 3,182,300 shares of Vita Coco Company, Inc., representing 5.5% of the outstanding common stock as of August 17, 2026. The filing indicates a passive investment intent, with no purpose or effect of changing or influencing control of the issuer.

• · The filing is made pursuant to Rule 13d-1(c), indicating a passive investment.
• · Fenelon Opportunity Fund Inc. is incorporated in Montana with a business address in Dallas, TX.
• · The filers disclaim any purpose of changing or influencing control of Vita Coco.
• · No prior period comparison is available as this is an initial filing for this filer.

17-08-2026

Thomas John Corley filed a Schedule 13G/A with the SEC on August 17, 2026, disclosing beneficial ownership of 370,000 shares of SOBR Safe, Inc. common stock, representing 6.9% of the 5,387,210 shares outstanding as of August 13, 2026. The filing indicates the shares were acquired and are held for investment purposes, not to influence control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
• · Thomas Corley's address is 132 Washington Place, State College, PA 16801.
• · The shares have a par value of $0.00001 per share.
• · The filing certifies the securities were not acquired to change or influence control of the issuer.

17-08-2026

Sequoia Capital entities filed Amendment No. 9 to their Schedule 13D, reporting an aggregate beneficial ownership of 18,596,961 shares (8.0%) of Maplebear Inc. common stock. The change reflects a pro rata in-kind distribution of shares by SCF and SCFP to partners/members for no consideration, effective August 13, 2026. No other transactions were reported since the prior amendment.

• · The distribution occurred on August 13, 2026, and was for no consideration.
• · The filing is Amendment No. 9 to the initial Schedule 13D filed on February 27, 2024.
• · The Reporting Persons may be deemed to constitute a 'group' under Rule 13(d)(3).
• · Each Reporting Person disclaims beneficial ownership of shares held by others.

17-08-2026

Joint Protein Central Inc. filed an amended Schedule 13G with the SEC on August 17, 2026, disclosing beneficial ownership of 1,200,000 shares of OSR Health, Inc. common stock, representing a 3.4% stake as of June 24, 2026. The filing indicates the shares are held for investment purposes and not with the intent to change or influence control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · The shares are held directly by Joint Protein Central Inc., a South Korea-based entity.
• · The filing certifies the securities were not acquired to change or influence control of the issuer.
• · OSR Health, Inc. was formerly known as OSR Holdings, Inc. and before that as Bellevue Life Sciences Acquisition Corp.

17-08-2026

8 Rivers Capital, LLC and related entities filed an amended Schedule 13D disclosing that 8RCH, LLC assigned its equity interests in Tillandsia, Areca, and Chamaedorea to Damian Beauchamp, resulting in 8RCH ceasing to be a 5% beneficial owner of NET Power Inc. Between May 14 and August 17, 2026, NPEH sold 1,722,100 shares of Class A Common Stock. The filing reflects a restructuring of ownership among existing insiders with no change in Mr. Beauchamp's overall beneficial ownership.

• · 8RCH, LLC assigned 50% of the outstanding equity of Tillandsia, Areca, and Chamaedorea to Damian Beauchamp, making him the direct 100% owner of each entity.
• · The assignment was effective as to 8 Rivers on August 17, 2026.
• · 8RCH was a disregarded entity wholly owned by Mr. Beauchamp prior to the assignment.
• · NPEH sold 1,722,100 shares of Class A Common Stock between May 14, 2026 and August 17, 2026.
• · No other transactions in the class of securities were effected by the Reporting Persons in the past 60 days.

17-08-2026

Starlite Capital Inc, along with The Gregory Fenelon Revocable Living Trust and Gregory Fenelon individually, filed a Schedule 13G/A disclosing beneficial ownership of 1,204,918 shares of Madison Square Garden Sports Corp. (MSGS) common stock, representing a 5.0% stake as of July 20, 2026. The filing indicates a passive investment intent, with no purpose or effect of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a prior Schedule 13G.
• · The filing date is August 17, 2026, with an event date of July 20, 2026.
• · The filing is made pursuant to Rule 13d-1(c), indicating a passive investor exemption.
• · No shares are held in any of the categories for shared voting power, shared dispositive power, or sole dispositive power (all reported as 0).
• · All 1,204,918 shares are held with sole voting power.

17-08-2026

Starlite Capital Inc, along with The Gregory Fenelon Revocable Living Trust and Gregory Fenelon individually, filed a Schedule 13G with the SEC on August 17, 2026, disclosing beneficial ownership of 9,722,960 shares of Take-Two Interactive Software Inc, representing 5.2% of the outstanding common stock. The filing indicates a passive investment intent under Rule 13d-1(c), with no purpose or effect of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Starlite Capital Inc is the parent holding company; Gregory Fenelon is the CEO and also individually holds shares.
• · The Gregory Fenelon Revocable Living Trust is an other entity type (OO) and also reports the same 9,722,960 shares.
• · No shares are held with shared voting or dispositive power (0 shares).
• · The filing date is August 17, 2026, and the event date is also August 17, 2026.

17-08-2026

Pablo Legorreta and his affiliated entities continue to hold significant beneficial ownership in Royalty Pharma plc, with Mr. Legorreta's total beneficial stake at 18.73% and Legorreta Investments, LLC at 7.76%. The filing reflects an adjustment due to a change in the number of Class A Shares outstanding (now 446,619,215), as well as minor recent transactions: an acquisition of 65,216 Class A Shares via equity award settlement and a gift of 30,000 limited partnership interests exchangeable for 300,000 Class A Shares. No other transactions occurred in the past 60 days.

• · Mr. Legorreta acquired 65,216 Class A Shares on August 5, 2026 via settlement of Equity Performance Awards (Rule 16b-3 exempt transaction).
• · Mr. Legorreta gifted 30,000 limited partnership interests (exchangeable for 300,000 Class A Shares) on August 7, 2026.
• · No other transactions were effected by the Reporting Persons in Class A or Class B Shares in the past 60 days.

17-08-2026

Jonathan M. Rothberg, founder and major shareholder of Butterfly Network, Inc., along with related entities, entered into a Rule 10b5-1 trading plan on August 14, 2026, allowing for the potential sale of up to 363,348 shares of Class A common stock and 8,049,929 shares of Class B common stock through November 12, 2027. On July 22, 2026, 659,913 shares of Class B common stock were sold at a weighted average price of $6.4698 per share, which automatically converted to Class A common stock upon sale. The filing reflects ongoing estate planning activities and does not indicate any change in the reporting persons' overall beneficial ownership strategy.

• · The 10b5-1 plan was entered into on March 13, 2026, and the effective date of the plan is August 14, 2026.
• · Sales under the plan may commence after the later of (a) 90 days following the cooling-off start date or two business days after a financial results notice, and (b) 120 days after the effective date.
• · The plan ends on November 12, 2027, unless all shares are sold earlier or other termination events occur.
• · The July 22, 2026 sale of 659,913 Class B shares was executed at a weighted average price of $6.4698 per share.
• · The reporting persons' beneficial ownership percentages: Jonathan M. Rothberg holds 0.3% of Class A common stock and 100% of Class B common stock (through 4C entities). 4C Holdings I, LLC holds 22.0% of Class B; 4C Holdings II, III, IV each hold 12.2%; 4C Holdings V holds 41.3%.
• · The filing is Amendment No. 12 to the original Schedule 13D filed on February 22, 2021.

17-08-2026

SR One Capital Management, LLC and affiliated entities filed Amendment No. 2 to Schedule 13D with the SEC on August 17, 2026, reporting that their aggregate beneficial ownership in Zenas BioPharma, Inc. decreased from a prior level to 7.7% (5,037,854 shares) due solely to an increase in total shares outstanding, not any sale of shares. The filing notes that no transactions in common stock were effected by the reporting persons during the last 60 days. The decrease in percentage ownership is a passive, non-trading event reflecting dilution from share issuance.

• · No transactions in common stock were effected by the reporting persons during the last 60 days.
• · The decrease in beneficial ownership percentage was solely due to an increase in total shares outstanding (dilution), not any sale of shares.
• · Total outstanding shares as of July 31, 2026: 65,176,723 shares (per Issuer's Form 10-Q filed August 13, 2026).

17-08-2026

Fenelon Opportunity Fund Inc., together with The Gregory Fenelon Revocable Living Trust and Gregory Fenelon individually, filed an amended Schedule 13G disclosing beneficial ownership of 2,077,816 common shares of Hyatt Hotels Corp, representing a 5.0% stake as of July 24, 2026. The filing is made under Rule 13d-1(c) and certifies that the securities were not acquired for the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
• · The filing date is August 17, 2026, with the event date of change being August 17, 2026.
• · The filer certifies the shares were not acquired to change or influence control of Hyatt Hotels Corp.

17-08-2026

Logos Global Management LP and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 10,538,440 shares of Achieve Life Sciences, Inc. (ACHV), representing 9.99% of the outstanding common stock as of August 11, 2026. The filing includes shares held directly by Logos Global Master Fund LP (5.1%) and Logos Opportunities Fund V LP (5.0%), along with options and warrants subject to a 9.99% ownership limitation. The reporting persons certify the securities were acquired in the ordinary course of business and not to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(b) and Rule 13d-1(c) of the Securities Exchange Act of 1934.
• · Each reporting person disclaims beneficial ownership except for their pecuniary interest, and disclaims membership in a group.
• · The securities were acquired in the ordinary course of business and not to change or influence control of the issuer.
• · A joint filing agreement was executed on August 17, 2026, appointing Logos Global Management LP as attorney-in-fact.

17-08-2026

Joseph H. Moglia and affiliated entities filed a Schedule 13G/A disclosing aggregate beneficial ownership of 630,500 shares of FG Nexus Inc. common stock, representing 12.37% of the 5,095,688 shares outstanding as of August 7, 2026. The filing indicates no change in control intent and is an amendment to a prior filing.

• · The filing is an amendment (13G/A) filed on August 17, 2026.
• · The shares are held indirectly through Moglia Capital LLC, Moglia Trust 1, and Moglia Trust 2.
• · The reporting persons certify that the securities were not acquired to change or influence control of the issuer.
• · The filing includes a Joint Filing Agreement among the reporting persons.

17-08-2026

Esousa Group Holdings LLC and its managing member Michael Wachs filed a Schedule 13G/A disclosing beneficial ownership of 319,429 shares of VivoSim Labs, Inc. common stock, representing 9.9% of the 3,194,295 shares outstanding as of June 30, 2026. The filing also notes an additional 576,542 shares issuable upon exercise of warrants, but those are subject to a beneficial ownership limitation that prevents exercise beyond the 9.9% threshold. The filing certifies the securities were not acquired to change or influence control of the issuer.

• · The filing is an amendment (Schedule 13G/A) filed on August 17, 2026.
• · The beneficial ownership limitation prevents exercise of warrants if it would result in ownership exceeding 9.9% of outstanding common stock.
• · The reporting persons certify the securities were not acquired to change or influence control of the issuer.

17-08-2026

Activant Ventures entities and related parties, led by Steven Sarracino, collectively own 8.9% of Better Home & Finance Holding Co.'s Class A common stock. On August 16, 2026, they executed a written stockholder consent to remove five directors (Harit Talwar, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan, and Daniel Lewis) without cause, effective upon delivery to the company. No additional transactions were reported since the prior amendment.

17-08-2026

Esousa Group Holdings LLC and its managing member Michael Wachs filed a Schedule 13G/A disclosing beneficial ownership of 821,469 ordinary shares of VCI Global Ltd, representing 9.9% of the outstanding shares as of June 30, 2026. The filing also notes that the reporting persons hold additional warrants for up to 4,889,976 ordinary shares, but these are subject to a 9.9% beneficial ownership limitation and were not exercisable as of the filing date.

• · The filing is an amendment (Schedule 13G/A) filed on August 17, 2026, with an event date of June 30, 2026.
• · Esousa Group Holdings LLC is a New York limited liability company; Michael Wachs is a U.S. citizen.
• · The beneficial ownership percentage is based on 7,542,584 ordinary shares outstanding as of June 1, 2026.
• · The warrants (Common A and Common B) are subject to a 9.9% beneficial ownership limitation, preventing exercise beyond that threshold.
• · The reporting persons certify that the securities were not acquired to change or influence control of the issuer.

17-08-2026

Diana Shipping Inc., the largest shareholder of Genco Shipping & Trading Ltd (GNK), has withdrawn its offer to acquire all outstanding GNK shares not already owned by Diana. The offer was comprised of $24.80 in cash (adjusted for a $0.80 dividend) plus one Diana share valued at $2.54. Diana withdrew the offer after the Genco Board demanded consideration valued at approximately $36.91 per share, a 57% premium to Genco's undisturbed share price, which Diana describes as 'outrageous' and 'disconnected from reality.' Diana remains Genco's largest shareholder with a 14.4% stake and intends to continue holding the board accountable.

• · Diana's offer was withdrawn after nine months of engagement and four proposals.
• · Genco Board's demands included $27.50 cash per share, $2.00 in dividends, and three Diana shares per Genco share.
• · Diana claims Genco abandoned VesselsValue valuations in favor of sell-side analyst NAV estimates after Diana's initial offer.
• · Genco's demanded NAV of $27.50 is above Clarksons equity analyst NAV ($25.40), Fearnleys equity analyst NAV ($25.00), and Diana's VesselsValue-based NAV ($25.00).
• · Diana states Genco management spent nearly $17 million of shareholder dollars in H1 2026 to protect personal interests.
• · Diana's fully committed financing was $1.412 billion.
• · Diana intends to regularly review its investment and may acquire or dispose of shares or engage in hedging transactions.

17-08-2026

Jared M. Kelly filed a Schedule 13G/A with the SEC on August 17, 2026, disclosing beneficial ownership of 138,317 shares of Marketwise, Inc. (MKTW) Class A Common Stock, representing a 4.72% stake. The filing indicates that Kelly has sole voting and dispositive power over all shares, with no shared or other ownership interests. This represents a reduction from a previously reported 4.7% ownership, as the current filing shows 138,317 shares held, unchanged from the prior period.

• · Jared M. Kelly's beneficial ownership is 4.72% of Marketwise, Inc.'s Class A Common Stock.
• · Kelly has sole voting power and sole dispositive power over all 138,317 shares.
• · No transactions were reported in the period between the prior filing and this amendment.

17-08-2026

The Francisco Trust disclosed a 10.32% beneficial ownership stake in Dyadic International Inc (DYAI) as of August 14, 2026, comprising 4,232,653 shares. This includes 3,280,272 shares held directly and 952,381 shares issuable upon conversion of a convertible promissory note (originally issued March 8, 2024, as amended) at a conversion price of $1.05 per share. The filing is an amendment to a previous Schedule 13G and indicates passive investment intent.

• · The convertible promissory note was originally issued on March 8, 2024, and has been amended.
• · Conversion price of the note is $1.05 per share.
• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · The trust's address is c/o Robert S. Levin, Esq., Trustee, 180 North LaSalle Street, Suite 3200, Chicago, IL 60601.

17-08-2026

This Schedule 13G/A amendment discloses that Shangzhao (Cizar) Hong, through HSZ Holdings Limited, beneficially owns 623,334 ordinary shares of Creative Global Technology Holdings Ltd, representing 36.26% of the outstanding shares as of August 13, 2026. The ownership consists of 56,667 Class A and 566,667 Class B ordinary shares, following a 1-for-15 reverse share split effective July 6, 2026. No changes in ownership were reported; the filing updates the percentage due to the reverse split.

• · The filing is an amendment to Schedule 13G, originally filed on August 12, 2025.
• · The reverse share split was 1-for-15, effective July 6, 2026.
• · CHSZ Holdings Limited, also controlled by Mr. Hong, owns 0 shares.
• · The ownership percentage is calculated based on 1,152,588 Class A and 566,667 Class B ordinary shares outstanding as of August 13, 2026.